Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 32 clinical trials
Observation in the Treatment of Graves' Disease

At present, there are still few observational studies on Graves' disease in China, and there are few research reports in this regard. In order to further carry out high-quality observational follow-up research on Graves' disease hyperthyroidism, including establishing standard diagnosis and treatment procedures, providing data support for the establishment of …

  • 22 Sep, 2021
  • 1 location
Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic

Sample Size: n=570 Accrual Ceiling: n=627 Study Population: Patients age 18 to 100 years Accrual Period: February 1, 2021 to September 30, 2022 Study Duration: Start Date: January 1, 2021 End Date: March 1, 2025 The study duration includes 18 months to recruit patients and 24 months of total follow-up …

  • 02 Sep, 2021
  • 2 locations
Evaluation of Patients With Thyroid Disorders

resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas. The main purpose of this study is to further understand the natural history, clinical presentation

growth hormone
thyroid hormone resistance
binding proteins
  • 19 Sep, 2023
  • 1 location
Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly

and metabolic diseases. Even if thyroid-stimulating hormone (TSH) is within the normal range, brain atrophy and infarction-like vascular damage in elderly males will be aggravated with the increased

Accepts healthy volunteers
  • 21 Aug, 2023
South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease (SDOI)

People with BMI >30 kg/m2 will be included in at population-based cohort. Additionally, one control group with BMI 18.5-25 kg/m2 and one control group with BMI 25-30 kg/m2 will be included. All participants with age 18 and 60 years. To evaluate health status participants will be screened by for undetected …

Accepts healthy volunteers
polycystic ovary syndrome
a 12
fatty liver
  • 24 Mar, 2022
  • 1 location
Morbidity Mortality Short and Long-term Survival of Hemodialysis End-stage Kidney Disease Patients in Central Tanzania

Background: In the last 2 decades, Tanzania made great improvements in the renal replacement therapy infrastructure and services. However, renal replacement therapy remains a challenge in the developing world in terms of inadequate renal registries, and limited published literature. Objectives: This study will identify predictors of mortality, identify common causes …

renal failure
renal replacement therapy
kidney replacement
  • 25 Jan, 2021
  • 1 location
Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents (IFCC-TSH)

of serum thyroid stimulating hormone (TSH) concentrations is an indispensable tool to confirm the disease and clinical management. Reference intervals (RI) reported along with the laboratory

  • 23 May, 2022
  • 1 location
Turner And Klinefelter Treatment Target Study (TAKTT)

testosterone in hair. For patients with Turner syndrome, free thyroxine (FT4), thyroid stimulating hormone (TSH) and liver enzymes, which have already been collected, will be investigated. The relationships

  • 13 Sep, 2023
  • 1 location
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?

Patients taking thyroid hormone replacement after thyroid removal surgery often report feeling differently than they did prior to taking thyroid hormone. The symptoms can include fatigue, worsening mood or subjective "brain fog" where the patient feels like their thinking is just not as sharp as it was previously. Multiple studies …

thyroid hormones
replacement therapy
levothyroxine therapy
  • 24 Feb, 2022
  • 1 location
Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly (SmartAge)

Cognitive disorders increase with age and in the presence of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM). In addition, digestive disorders, changes in dietary pattern and decreased activity negatively influence the microbiome. The hypothesis is that pharmacological intervention with metformin will modify the composition of the gut microbiota …

continuous glucose monitoring
type 2 diabetes mellitus
  • 04 Oct, 2022
  • 1 location